These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16821260)

  • 1. The predictive power of anti-cyclic citrullinated peptide antibodies: window into understanding gene/ environment/immunity interactions.
    Lee W; Weisman MH
    J Rheumatol; 2006 Jul; 33(7):1216-8. PubMed ID: 16821260
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of anti-cyclic citrullinated peptide antibodies in predicting progression of palindromic rheumatism to rheumatoid arthritis.
    Russell AS; Devani A; Maksymowych WP
    J Rheumatol; 2006 Jul; 33(7):1240-2. PubMed ID: 16724377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of anticyclic citrullinated peptide antibody in rheumatoid arthritis.
    Jansen TL; Bruyn GA
    J Rheumatol; 2004 May; 31(5):1012-3; author reply 1013. PubMed ID: 15124273
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-CCP antibodies as an aid to prioritization of patients referred to the rheumatology clinic.
    Madan A; Belshaw R; Grennan D
    QJM; 2007 Nov; 100(11):737-8. PubMed ID: 17951317
    [No Abstract]   [Full Text] [Related]  

  • 5. Testing for anti-cyclic citrullinated peptide antibodies: is it time to set this genie free?
    Shmerling RH
    Arch Intern Med; 2009 Jan; 169(1):9-14. PubMed ID: 19139318
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
    Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
    J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis.
    Liu X; Jia R; Zhao J; Li Z
    J Rheumatol; 2009 Jun; 36(6):1136-42. PubMed ID: 19447936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [immunological and serological tests for diagnosis of rheumatoid arthritis: antinuclear antibodies].
    Hirakata M; Kaneko Y
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():333-40. PubMed ID: 15799373
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiperinuclear factor test is more useful than anti-Sa assay when used with anti-cyclic citrullinated peptide test in diagnosis of rheumatoid arthritis.
    Kim DA; Jearn LH; Kim TY
    J Rheumatol; 2007 Sep; 34(9):1944-5. PubMed ID: 17787055
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-CCP antibody testing as a diagnostic and prognostic tool in rheumatoid arthritis.
    Niewold TB; Harrison MJ; Paget SA
    QJM; 2007 Apr; 100(4):193-201. PubMed ID: 17434910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can we rely on anti-citrulline antibody determination for the diagnosis of early rheumatoid arthritis?
    Bell DA
    J Rheumatol; 2006 Dec; 33(12):2369-71. PubMed ID: 17143974
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides.
    Innala L; Kokkonen H; Eriksson C; Jidell E; Berglin E; Dahlqvst SR
    J Rheumatol; 2008 Jun; 35(6):1002-8. PubMed ID: 18398946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-cyclic citrullinated peptide testing for the diagnosis of rheumatoid arthritis and the quest for improved sensitivity and predictive value.
    Levesque MC; Zhou Z; Moreland LW
    Arthritis Rheum; 2009 Aug; 60(8):2211-5. PubMed ID: 19644881
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of second- and third-generation anti-cyclic citrullinated peptide antibodies assays for detecting rheumatoid arthritis.
    Lutteri L; Malaise M; Chapelle JP
    Clin Chim Acta; 2007; 386(1-2):76-81. PubMed ID: 17826752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Easy and accurate diagnosis of rheumatoid arthritis using anti-cyclic citrullinated peptide 2 antibody, swollen joint count, and C-reactive protein/rheumatoid factor.
    Yamane T; Hashiramoto A; Tanaka Y; Tsumiyama K; Miura Y; Shiozawa K; Chihara K; Shiozawa S
    J Rheumatol; 2008 Mar; 35(3):414-20. PubMed ID: 18203327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can anticyclic citrullinated peptide antibodies be used to successfully monitor treatment in rheumatoid arthritis patients?
    Vallbracht LL
    South Med J; 2006 Nov; 99(11):1197-8. PubMed ID: 17195406
    [No Abstract]   [Full Text] [Related]  

  • 17. [Predictive factors in prognosis of rheumatoid arthritis].
    Matsuda T
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():19-23. PubMed ID: 15799311
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-cyclic citrullinated peptide in preclinical rheumatoid arthritis. Food for thought.
    Ménard HA
    J Rheumatol; 2009 Apr; 36(4):663-4. PubMed ID: 19342718
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anti-citrullinated peptide antibodies: novel markers for rheumatoid polyarthritis].
    Yalaoui S
    Arch Inst Pasteur Tunis; 2006; 83(1-4):13-7. PubMed ID: 19388592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of anticyclic citrullinated peptide in the diagnosis of early rheumatoid factor-negative suspected rheumatoid arthritis: is it worthwhile to order the test?
    Panchagnula R; Rajiv SR; Prakash J; Chandrashekara S; Suresh KP
    J Clin Rheumatol; 2006 Aug; 12(4):172-5. PubMed ID: 16891919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.